These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [A case of a papillary cystadenoma of boundary malignancy in a 29-year old female patient with high surgical risk]. Angelova M; Lazarov N; Gŭlŭbova M; Vasilev I Akush Ginekol (Sofiia); 2005; 44(7):41-2. PubMed ID: 16544719 [TBL] [Abstract][Full Text] [Related]
48. Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate. Huang PY; Chu CY; Hsiao CH J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S81-4. PubMed ID: 17097372 [TBL] [Abstract][Full Text] [Related]
49. Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha. Korkmaz C; Temiz G; Cetinbas F; Büyükkidan B Rheumatology (Oxford); 2004 Jul; 43(7):937-8. PubMed ID: 15213343 [No Abstract] [Full Text] [Related]
50. Unexpected IgA nephropathy during the treatment of a young woman with idiopathic dermatomyositis: case report and review of the literature. Yen TH; Huang JY; Chen CY J Nephrol; 2003; 16(1):148-53. PubMed ID: 12649547 [TBL] [Abstract][Full Text] [Related]
51. Topical tacrolimus treatment in a patient with dermatomyositis. Lampropoulos CE; D' Cruz DP Ann Rheum Dis; 2005 Sep; 64(9):1376-7. PubMed ID: 16100347 [No Abstract] [Full Text] [Related]
52. [Report of a case of paraneoplastic dermatomyositis]. Gouttard ; Domenach ; Riffat J Med Lyon; 1972 Apr; 53(227):565-8. PubMed ID: 5083142 [No Abstract] [Full Text] [Related]
53. Serum CA-125 screening for ovarian cancer in patients with dermatomyositis. Whitmore SE; Anhalt GJ; Provost TT; Zacur HA; Hamper UM; Helzlsouer KJ; Rosenshein NB Gynecol Oncol; 1997 May; 65(2):241-4. PubMed ID: 9159332 [TBL] [Abstract][Full Text] [Related]
54. Three differently timed presentations of dermatomyositis associated with advanced ovarian cancer. Flynn M; Ottaway Z; Kaur J; Waters J BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30257970 [TBL] [Abstract][Full Text] [Related]
55. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases. Dinh HV; McCormack C; Hall S; Prince HM J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377 [TBL] [Abstract][Full Text] [Related]
56. Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis. Sangle VS; Sangle SR; D'Cruz DP Ann Rheum Dis; 2008 May; 67(5):723. PubMed ID: 18408111 [No Abstract] [Full Text] [Related]
57. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595 [TBL] [Abstract][Full Text] [Related]
58. [Dermatomyositis as a first symptom of malignant tumour (author's transl)]. Kastl J; Horácek J Cesk Dermatol; 1979 Apr; 54(2):79-82. PubMed ID: 427888 [No Abstract] [Full Text] [Related]
59. Dermatomyositis treated with cyclosporin. Kavanagh GM; Ross JS; Black MM J R Soc Med; 1991 May; 84(5):306. PubMed ID: 2041011 [No Abstract] [Full Text] [Related]
60. Giant malignant ovarian tumor: a case report. Manchanda R; Kriplani A Int J Gynecol Cancer; 2005; 15(6):1135-7. PubMed ID: 16343196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]